Didactic

(a) Overview of practitioner/facilitator responsibilities including how to work as part of a care team;

(b) 42 CFR part 2;

(c) Trauma-informed Care

(d) Psychedelic emergencies, urgencies, complications, and medical monitoring;

(e) Safety, risk mitigation, and harm reduction practices;

(f) Psilocybin actions and effects on the body, interactions, and pharmacology;

(g) Drug interactions and pharmacology;

(h) Set and setting;

(i) Ethics in therapeutic settings;

(j) Legal considerations;

(k) Cultural competencies;

(l) Traditional and ceremonial practices and considerations;

(m) Equity and access;

(n) Patient-centered approaches and care;

(o) Education on the qualifying conditions and appropriate treatment practices;

(p) Preparation and integration sessions;

(q) Administration session;

(r) Dosing;

(s) Psychedelic de-escalation techniques;

(t) Non-ordinary states of consciousness;

(u) Self-care;

(v) Research and data collection requirements;

(w) Evidence-informed practices and research updates;

(x) Informed consent;

(y) Touch and somatic awareness;

(z) Continuity of care and creating care plans.